HK1249043A1 - 具有改善的聚集性質的液體抗體製劑 - Google Patents
具有改善的聚集性質的液體抗體製劑Info
- Publication number
- HK1249043A1 HK1249043A1 HK18108863.7A HK18108863A HK1249043A1 HK 1249043 A1 HK1249043 A1 HK 1249043A1 HK 18108863 A HK18108863 A HK 18108863A HK 1249043 A1 HK1249043 A1 HK 1249043A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibody formulation
- aggregation properties
- liquid antibody
- improved aggregation
- improved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261740193P | 2012-12-20 | 2012-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1249043A1 true HK1249043A1 (zh) | 2018-10-26 |
Family
ID=50979394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18108863.7A HK1249043A1 (zh) | 2012-12-20 | 2018-07-09 | 具有改善的聚集性質的液體抗體製劑 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20150344557A1 (zh) |
EP (2) | EP2934588A4 (zh) |
JP (1) | JP6326066B2 (zh) |
AU (1) | AU2013361587A1 (zh) |
CA (1) | CA2895198A1 (zh) |
HK (1) | HK1249043A1 (zh) |
WO (1) | WO2014100143A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR102198A1 (es) | 2014-10-09 | 2017-02-08 | Regeneron Pharma | Proceso para reducir partículas subvisibles en una formulación farmacéutica |
US11229702B1 (en) | 2015-10-28 | 2022-01-25 | Coherus Biosciences, Inc. | High concentration formulations of adalimumab |
US11071782B2 (en) * | 2016-04-20 | 2021-07-27 | Coherus Biosciences, Inc. | Method of filling a container with no headspace |
SG11201900201YA (en) | 2016-08-16 | 2019-02-27 | Regeneron Pharma | Methods for quantitating individual antibodies from a mixture |
SG11201902667UA (en) | 2016-10-25 | 2019-05-30 | Regeneron Pharma | Methods and systems for chromatography data analysis |
TW202005694A (zh) | 2018-07-02 | 2020-02-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
JPWO2021153511A1 (zh) * | 2020-01-28 | 2021-08-05 | ||
US11642280B2 (en) * | 2020-11-10 | 2023-05-09 | Corning Incorporated | Glass containers and sealing assemblies for maintaining seal integrity at low storage temperatures |
CN117794516A (zh) | 2021-08-13 | 2024-03-29 | 生物测试股份公司 | 纤维蛋白原组合物和制备方法 |
WO2023056464A1 (en) | 2021-09-30 | 2023-04-06 | Corning Incorporated | Glass containers for storing pharmaceutical compositions |
AU2021471595A1 (en) * | 2021-10-29 | 2024-05-09 | Nascent Biotech, Inc. | Kits and containers for treating vimentin expressing tumors |
US11492394B1 (en) | 2021-10-29 | 2022-11-08 | Nascent Biotech, Inc. | Kits and containers for treating vimentin expressing tumors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
ATE389414T1 (de) * | 1999-09-08 | 2008-04-15 | Chugai Pharmaceutical Co Ltd | Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
EP2284194A1 (en) | 2004-12-21 | 2011-02-16 | AstraZeneca AB | Antibodies directed to angiopoietin-2 and uses thereof |
SG170837A1 (en) * | 2006-04-05 | 2011-05-30 | Abbott Biotech Ltd | Antibody purification |
MX2010008099A (es) * | 2008-01-28 | 2010-08-04 | Medimmune Ltd | Anticuerpos y angiopoyetina-2 estabilizados y sus usos. |
EP2471554A1 (en) * | 2010-12-28 | 2012-07-04 | Hexal AG | Pharmaceutical formulation comprising a biopharmaceutical drug |
-
2013
- 2013-12-18 CA CA2895198A patent/CA2895198A1/en not_active Abandoned
- 2013-12-18 US US14/653,357 patent/US20150344557A1/en not_active Abandoned
- 2013-12-18 WO PCT/US2013/076062 patent/WO2014100143A2/en active Application Filing
- 2013-12-18 JP JP2015549615A patent/JP6326066B2/ja active Active
- 2013-12-18 AU AU2013361587A patent/AU2013361587A1/en not_active Abandoned
- 2013-12-18 EP EP13866178.0A patent/EP2934588A4/en not_active Withdrawn
- 2013-12-18 EP EP17163164.1A patent/EP3266466A1/en not_active Withdrawn
-
2018
- 2018-01-03 US US15/860,761 patent/US20180243415A1/en not_active Abandoned
- 2018-07-09 HK HK18108863.7A patent/HK1249043A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20180243415A1 (en) | 2018-08-30 |
JP6326066B2 (ja) | 2018-05-16 |
EP3266466A1 (en) | 2018-01-10 |
WO2014100143A3 (en) | 2014-08-14 |
EP2934588A4 (en) | 2016-09-28 |
WO2014100143A2 (en) | 2014-06-26 |
JP2016506409A (ja) | 2016-03-03 |
EP2934588A2 (en) | 2015-10-28 |
CA2895198A1 (en) | 2014-06-26 |
AU2013361587A1 (en) | 2015-06-18 |
US20150344557A1 (en) | 2015-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249043A1 (zh) | 具有改善的聚集性質的液體抗體製劑 | |
HK1203146A1 (zh) | 抗體製劑 | |
HK1214499A1 (zh) | 穩定的低粘度抗體配製品 | |
HK1208372A1 (zh) | 液體製劑 | |
EP2844118A4 (en) | LIQUID DISPENSER WITH ADJUSTABLE DOSAGE | |
HK1211862A1 (zh) | 納米顆粒製劑 | |
GB201221389D0 (en) | Metered pourer | |
EP2894033A4 (en) | DEVICE FOR DISPENSING LIQUID DROPS | |
HK1216241A1 (zh) | 提高了穩定性的液體分配器 | |
HK1215796A1 (zh) | 抗體製劑 | |
HK1199844A1 (zh) | 抗體配方 | |
EP2839825A4 (en) | LIQUID COSMETIC PREPARATION | |
HK1196112A1 (zh) | 自封口容器 | |
GB201315537D0 (en) | Liquid mixer | |
TH1401001742B (th) | ภาชนะบรรจุสำหรับใช้กับของเหลว | |
GB201321028D0 (en) | Metered pourer | |
AU2012902062A0 (en) | Liquid Formulation | |
GB201206991D0 (en) | Liquid container |